Deep Brain Stimulation Effects on Gait and Balance in Patients With Parkinson's Disease
Stopped early · Not applicable
Conditions studied: Parkinson's Disease
In brief
The purpose of this study is to evaluate the effect of Deep Brain stimulation (DBS) on walking in patients with Parkinson's disease that have had DBS. While DBS improves Parkinson's disease (PD) symptoms and walking in many patients in some of the patients walking problems persist. This study aims to find out what are the best stimulation parameters of the DBS in order to improve walking.
Key facts
- Study ID
- NCT02022735
- Run by
- University of Miami
- People needed
- 22
- Starts
- 2013-09-01
- Expected to finish
- 2017-12-01
- Last updated by the study team
- 2021-05-28
Who can join
Age: 45 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with idiopathic Parkinson's disease stage 1-3 that underwent subthalamic nucleus (STN) Deep Brain Stimulation (DBS) and have walking difficulties 6-12 months after DBS.
- On stable dose of dopaminergic drugs
- Age 45-70 years of age
You may not qualify if…
- Past medical history of seizures
- Renal insufficiency
- Cardiac arrhythmia
- Severe arthritis
- Women of childbearing potential
- Dementia
- Less than 45 years of age or older than 70 years of age
Where it is running
- University of Miami — Miami, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.